Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04879810 · ClinicalTrials.gov registry record · NA
Plant Exosomes +/- Curcumin to Abrogate Symptoms of Inflammatory Bowel Disease
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04879810 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 4 participants.
The verdict
NCT04879810, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The trial will test the hypothesis that edible structures within plant cells (ginger) will have clinically important anti-inflammatory effects on the gut lining of patients with inflammable bowel disease. To evaluate the safety and tolerability of exosomes with and without curcumin in patients with Inflammatory Bowel Disease (IBD); To estimate the effect of ginger exosomes or curcumin alone or combined with curcumin on the symptoms and disease score in patients with refractory IBD describe toxicities associated with ginger exosomes; to evaluate the effect of ginger exosomes on biomarkers of inflammation.
Interventions
- PROCEDURE Sigmoidoscopy and biopsy, blood work
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2022-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04879810
The ClinicalTrials.gov registry entry for NCT04879810 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sigmoidoscopy and biopsy, blood work is the first listed.
NCT04879810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04879810 about?
NCT04879810 is a clinical study titled "Plant Exosomes +/- Curcumin to Abrogate Symptoms of Inflammatory Bowel Disease". The trial will test the hypothesis that edible structures within plant cells (ginger) will have clinically important anti-inflammatory effects on the gut lining of patients with inflammable bowel disease. To evaluate the safety and tolerability of exosomes with and without curcumin in patients with...
What is the current status of trial NCT04879810?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2018-03-01. Estimated completion is 2022-08-02.
What interventions are being tested in trial NCT04879810?
The interventions under investigation include: Sigmoidoscopy and biopsy, blood work (PROCEDURE).
Who is sponsoring clinical trial NCT04879810?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.